FDJ UNITED: Combined General Meeting of 22 May 2025
The annual and extraordinary Ordinary General Meeting of La Française des Jeux (Paris:FDJ) was held this Thursday, 22 May, under the chairmanship of Stéphane Pallez, Chairwoman and CEO. Shareholders were able to cast their votes during the General Meeting on presentation of an admission card. Shareholders who were unable to physically attend the meeting were able to vote by post, by proxy or via the secure Votaccess platform prior to the General Meeting.
The General Meeting largely adopted all the resolutions put to the vote of the shareholders, including:
- The approval of the parent company and consolidated financial statements for the 2024 financial year;- The appropriation of earnings for the financial year ended 31 December 2024 and the payment of a dividend of €2.05 per share to be paid on 3 June 2025;- The appointment of Ms Alix Boulnois as director;- The components of remuneration of the corporate directors for the 2024 financial year, as well as the 2025 remuneration policy for corporate directors;- Various financial authorisations granted to the Board of Directors;- Various amendments to the Articles of Association in order to incorporate the new purpose of FDJ UNITED in the preamble.
In 2026, the General Meeting will be held on 23 April.
Continuation of the liquidity agreement – Implementation of the share buyback programme
Today's General Meeting adopted, in its 11th resolution, a new share buyback programme.
A description of this programme can be found in the 2024 Universal Registration Document (chapter 7.2.2.1) filed on 29 April 2025 with the AMF and available on the FDJ website (www.groupefdj.com).
On 15 April 2025, the Board of Directors decided, subject to the condition precedent of the adoption of the 11th resolution of the General Meeting, to implement this programme in order to continue the liquidity agreement entered into with Exane.
Resignation of Mrs Barjou - Director
Following Predica's withdrawal from FDJ UNITED, Florence Barjou has tendered her resignation. The Chairman and CEO thanks her for her commitment and contribution to the Board of Directors of FDJ UNITED since March 1, 2022.
About FDJ UNITED
FDJ UNITED is one of Europe's leading betting and gaming operators, with a vast portfolio of iconic brands and a reputation for technological excellence. With more than 5,000 employees and a presence in around fifteen regulated markets, the Group offers a diversified, responsible range of games, both under exclusive rights and open to competition: lottery games in France and Ireland, via an extensive point-of-sale network and online; sports betting at points of sale in France; and online games open to competition (sports and horse-race betting, poker and online casino games, in markets where these activities are authorized). FDJ Group has placed responsibility at the heart of its strategy and promotes recreational betting. FDJ Group is listed on the Euronext Paris regulated market (FDJU) and is a member of indices including the SBF 120, Euronext 100, Euronext Vigeo 20, EN EZ ESG L 80, STOXX Europe 600, MSCI Europe and FTSE Euro.
For more information, visit www.fdjunited.com
X @FDJUNITED Instagram @FDJUNITED_officiel LinkedIn @FDJUNITED
View source version on businesswire.com: https://www.businesswire.com/news/home/20250523879454/en/
Contacts
Media +33 (0)1 41 10 33 82 | media@fdjunited.com
Investor Relations+33 (0)1 41 04 19 74 | invest@fdjunited.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Aegis Resources Ltd. Announces an Increase in its Non-brokered Private Placement
This news release is not for distribution to United States newswire service or for dissemination in the United States Vancouver, B.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aegis Resources Ltd. ('Aegis' or the 'Company') announces that due to subscriber demand, its board of directors has approved an increase to its private placement (the 'Placement'). The increased Placement will consist of up to 12,000,000 common shares, up from the 10,000,000 common shares previously announced on August 7, 2025, in the authorized share structure of the Company at a price of $0.10 per share for gross proceeds of up to $1,200,000. All other terms of the Placement will remain the same. All securities issued pursuant to the Placement will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws. The securities of the Company are not listed for trading on any stock exchange and there is no current intention to list the securities on any stock exchange. Consequently, there is no market through which the securities of the Company may be sold. Proceeds of the Placement will be used for exploration and general administration expenses. Aegis Resources Ltd. is an unlisted public company with a strategic portfolio of mineral exploration assets in Argentina, Colombia and Australia, spun out of Rugby Resources Ltd. on July 25, 2025. The Company's strategy is to advance its projects through exploration and seek joint venture partners to minimize dilution and maximize returns. For additional information you are invited to visit the Aegis Resources Ltd. website at: Alejandro Adams, Director+1 604.688.4941Suite 1890 – 1075 West Georgia BC Canada. V6E 3C9info@ in to access your portfolio
Yahoo
4 hours ago
- Yahoo
Leonteq Publishes Voting Results of Its Extraordinary General Meeting 2025
ZURICH - August 20, 2025 (NEWMEDIAWIRE) - Leonteq AG (SIX: LEON) shareholders agreed to all the proposals put forward by the Board of Directors at today's Extraordinary General Meeting. Approximately 63% of Leonteq's issued shares were represented at today's virtual meeting. 1,085 shareholders were represented by the independent proxy with 11,652,358 shares, while 13 shareholders with 65,513 shares participated online. Shareholders approved the proposed changes to the Articles of Association as well as a significant reduction in the maximum compensation for the members of the Executive Committee for the financial year 2026. For further details of the voting results for all proposals presented at the Extraordinary General Meeting 2025, please visit Leonteq's website at CONTACTMedia Relations +41 58 800 1844media@ Investor Relations +41 58 800 1855investorrelations@ LEONTEQ Leonteq is a Swiss fintech company with a leading marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services and predominantly covers the capital protection, yield enhancement and participation product classes. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has offices and subsidiaries in 13 countries across Europe, the Middle East and Asia. Leonteq AG has a BBB credit rating by Fitch Ratings, was assigned with an AA ESG rating by MSCI and is listed on the SIX Swiss Exchange (SIX: LEON). DISCLAIMER This press release issued by Leonteq AG (the "Company") serves for information purposes only and does not constitute research. This press release and all materials, documents and information used therein or distributed in the context of this press release do not constitute or form part of and should not be construed as, an offer (public or private) to sell or a solicitation of offers (public or private) to purchase or subscribe for shares or other securities of the Company or any of its affiliates or subsidiaries in any jurisdiction or an inducement to enter into investment activity in any jurisdiction, and may not be used for such purposes. Copies of this press release may not be made available (directly or indirectly) to any person in relation to whom the making available of the press release is restricted or prohibited by law or sent to countries, or distributed in or from countries, to, in or from which this is restricted or prohibited by law. This press release may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "target" "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the Company or any of its affiliates or subsidiaries and those explicitly or implicitly presumed in these statements. These factors include, but are not limited to: (1) general market, macroeconomic, governmental and regulatory trends, (2) movements in securities markets, exchange rates and interest rates and (3) other risks and uncertainties inherent in our business. Against the background of these uncertainties, you should not rely on forward-looking statements. Neither the Company nor any of its affiliates or subsidiaries or their respective bodies, executives, employees and advisers assume any responsibility to prepare or disseminate any supplement, amendment, update or revision to any of the information, opinions or forward-looking statements contained in this press release or to adapt them to any change in events, conditions or circumstances, except as required by applicable law or regulation. Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
Nordson Corporation Reports Third Quarter Fiscal 2025 Results and Updates Full Year Guidance
Third Quarter Highlights: Sales were $742 million, an increase of 12% year-over-year Earnings per diluted share were $2.22 Adjusted earnings per diluted share were $2.73, up 13% year-over-year Free cash flow conversion of 180% of net income Board of Directors approved a new $500 million share repurchase authorization WESTLAKE, Ohio, August 20, 2025--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal third quarter ended July 31, 2025. Sales were $742 million compared to the prior year's third quarter sales of $662 million. The third quarter 2025 sales included a favorable acquisition impact of 8%, an organic sales increase of 2% and a favorable currency translation impact of 2%. Net income was $126 million, or $2.22 of earnings per diluted share, compared to prior year's third quarter net income of $117 million, or $2.04 of earnings per diluted share. Excluding charges associated with the exit of the medical contract manufacturing business and acquisition-related amortization and costs, third quarter adjusted net income was $155 million versus prior year adjusted net income of $138 million. Third quarter adjusted earnings per diluted share were $2.73, a 13% increase from the prior year adjusted earnings per diluted share of $2.41. EBITDA in the third quarter was $239 million, or 32% of sales, an increase of 15% compared to prior year EBITDA of $208 million, or 31% of sales. Commenting on the Company's fiscal 2025 third quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, "The Nordson team responded effectively to dynamic demand conditions in key end markets and delivered on its promises, realizing solid year-over-year organic growth in the quarter. In particular, the Advanced Technology Solutions segment delivered 15% organic sales growth. Operational excellence drove strong profit performance, increasing adjusted earnings per share by 13% and EBITDA by 15%. In this final full quarter of Atrion's first year acquisition performance, our new employees again exceeded expectations and contributed to both sales and earnings results. Also this quarter, we maintained a strong balance sheet, delivering cash flow conversion of 180% of net income that we used to reduce debt, repurchase shares and return dividends to shareholders, while continuing to invest in the company." Third Quarter Segment Results Industrial Precision Solutions sales of $351 million increased 1% from the prior year, inclusive of an organic sales decrease of 2% and favorable currency translation of 3%. The organic sales decrease was driven by weaker systems demand in polymer processing offsetting growth in most other product lines. Operating profit was $117 million, an increase of $2 million from the prior year. EBITDA in the quarter was $130 million, or 37% of sales, compared to prior year third quarter EBITDA of $131 million, or 37% of sales. Medical and Fluid Solutions sales of $219 million increased 32% compared to the prior year third quarter, inclusive of an acquisition impact of 31% and a favorable currency impact of 1%. Organic sales were flat inclusive of the contract manufacturing business that is held for sale. Excluding the pending divestiture in both periods, organic sales increased 4% driven by medical fluid components and fluid solutions product lines. Operating profit was $53 million, an increase of $4 million from the prior year. Excluding acquisition costs and charges associated with the exit of the medical contract manufacturing business, operating profit was $65 million, an increase of $17 million from the prior year reflecting increased leverage of selling, general and administrative expenses in the core business, as well as contribution from the Atrion acquisition. EBITDA in the quarter was $83 million, or 38% of sales, up 34% versus the prior year third quarter EBITDA of $62 million, or 37% of sales. Advanced Technology Solutions sales of $171 million increased 17% compared to the prior year third quarter, inclusive of an organic sales increase of 15% and favorable currency translation of 3%. The organic sales increase compared to prior year was driven by robust growth in electronics dispense product lines. Operating profit was $37 million, an increase of $11 million due to the strong conversion on increased organic sales. EBITDA in the quarter was $42 million, or 24% of sales, up 35% from the prior year third quarter EBITDA of $31 million, or 21% of sales. Outlook Backlog is down approximately 5% sequentially following a strong third quarter. This supports achieving the Company's original full year sales and earnings guidance, assuming completion of the pending divestiture of the medical contract manufacturing business in the fourth quarter. Fiscal full year sales are now tracking slightly below the mid-point and full year adjusted earnings per share are now tracking slightly above the mid-point of our original guidance. Reflecting on the full year outlook, Nagarajan said, "Following a strong third quarter, I am pleased that we are able to affirm our full year sales guidance and earnings expectations. NBS Next is driving organic growth by enhancing our new product vitality, best-in-class quality and delivery, while also empowering our teams to respond quickly to changing customer demand. Through our close-to-customer business model, diverse product portfolio and in-region, for-region manufacturing strategy, we have continuously demonstrated resilience and the ability to deliver solid growth and best-in-class profitability in varying market scenarios." Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, August 21, 2025, at 8:30 a.m. eastern time, which can be accessed at Information about Nordson's investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or The Company's definition of adjusted earnings excludes restructuring, business exit and acquisition related cost / amortization for both current and historical periods. It is not possible for the Company to identify the amount or significance of future adjustments associated with acquisition and integration costs, restructuring costs, acquisition-related amortization, certain non-operating or income tax items, or other non-routine costs that the Company adjusts in the presentation of adjusted earnings guidance. These items are dependent on future events that are not reasonably estimable at this time. Accordingly, the Company is unable to reconcile without unreasonable effort the forecasted range of adjusted earnings guidance to a comparable GAAP range. Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as "may," "will," "should," "could," "expects," "anticipates," "believes," "projects," "forecasts," "outlook," "guidance," "continue," "target," or the negative of these terms or comparable terminology. These statements reflect management's current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company's ability to successfully integrate acquisitions; the Company's ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the U.S. or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics and the other factors discussed in Item 1A (Risk Factors) in the Company's most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release. Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company's direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at linkedin/Nordson, or NORDSON CORPORATION CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Dollars in thousands except for per-share amounts) Three Months Ended Nine Months Ended July 31, 2025 July 31, 2024 July 31, 2025 July 31, 2024 Sales $ 741,509 $ 661,604 $ 2,039,867 $ 1,945,439 Cost of sales 334,992 292,603 923,550 862,134 Gross profit 406,517 369,001 1,116,317 1,083,305 Gross margin % 54.8 % 55.8 % 54.7 % 55.7 % Selling & administrative expenses 206,539 201,943 606,642 588,196 Divestiture and related charges 12,211 — 12,211 — Operating profit 187,767 167,058 497,464 495,109 Interest expense - net (25,698 ) (17,776 ) (77,335 ) (56,729 ) Other income (expense) - net (2,945 ) 152 (5,380 ) (971 ) Income before income taxes 159,124 149,434 414,749 437,409 Income taxes 33,340 32,107 81,909 92,293 Net income $ 125,784 $ 117,327 $ 332,840 $ 345,116 Weighted-average common shares outstanding: Basic 56,438 57,229 56,784 57,171 Diluted 56,728 57,624 57,084 57,620 Earnings per share: Basic earnings $ 2.23 $ 2.05 $ 5.86 $ 6.04 Diluted earnings $ 2.22 $ 2.04 $ 5.83 $ 5.99 NORDSON CORPORATION CONSOLIDATED BALANCE SHEETS (Unaudited) (Dollars in thousands) July 31, 2025 October 31, 2024 Cash and cash equivalents $ 147,788 $ 115,952 Receivables - net 588,951 594,663 Inventories - net 459,251 476,935 Other current assets 91,275 87,482 Assets held for sale 39,583 — Total current assets 1,326,848 1,275,032 Property, plant and equipment - net 525,604 544,607 Goodwill 3,306,432 3,280,819 Other assets 850,829 900,508 $ 6,009,713 $ 6,000,966 Notes payable and debt due within one year $ 336,078 $ 103,928 Accounts payable and accrued liabilities 436,223 424,549 Liabilities held for sale 10,807 — Total current liabilities 783,108 528,477 Long-term debt 1,785,745 2,101,197 Other liabilities 459,075 439,100 Total shareholders' equity 2,981,785 2,932,192 $ 6,009,713 $ 6,000,966 NORDSON CORPORATION CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Dollars in thousands) Nine Months Ended July 31, 2025 July 31, 2024 Cash flows from operating activities: Net income $ 332,840 $ 345,116 Depreciation and amortization 112,454 99,646 Divestiture and related charges 12,211 — Other non-cash items 12,154 15,435 Changes in operating assets and liabilities and other 46,605 (385 ) Net cash provided by operating activities 516,264 459,812 Cash flows from investing activities: Additions to property, plant and equipment (49,002 ) (43,786 ) Other - net 4,272 8,896 Net cash used in investing activities (44,730 ) (34,890 ) Cash flows from financing activities: Repayment of long-term debt - net (94,664 ) (244,355 ) Repayment of finance lease obligations (4,083 ) (4,505 ) Dividends paid (133,008 ) (116,789 ) Issuance of common shares 5,419 29,142 Purchase of treasury shares (218,194 ) (34,105 ) Net cash used in financing activities (444,530 ) (370,612 ) Effect of exchange rate change on cash: 4,832 (4,665 ) Net change in cash and cash equivalents 31,836 49,645 Cash and cash equivalents: Beginning of period 115,952 115,679 End of period $ 147,788 $ 165,324 NORDSON CORPORATION SALES BY GEOGRAPHIC SEGMENT (Unaudited) (Dollars in thousands) Three Months Ended Sales Variance July 31, 2025 July 31, 2024 Organic Acquisitions Currency Total SALES BY SEGMENT Industrial Precision Solutions $ 350,784 $ 348,997 (2.0 )% — % 2.5 % 0.5 % Medical and Fluid Solutions 219,465 166,737 (0.4 )% 31.0 % 1.0 % 31.6 % Advanced Technology Solutions 171,260 145,870 14.6 % — % 2.8 % 17.4 % Total sales $ 741,509 $ 661,604 2.1 % 7.8 % 2.2 % 12.1 % SALES BY GEOGRAPHIC REGION Americas $ 314,568 $ 287,016 (3.2 )% 13.0 % (0.2 )% 9.6 % Europe 186,620 179,370 (6.1 )% 4.8 % 5.3 % 4.0 % Asia Pacific 240,321 195,218 17.4 % 2.9 % 2.8 % 23.1 % Total sales $ 741,509 $ 661,604 2.1 % 7.8 % 2.2 % 12.1 % Nine Months Ended Sales Variance July 31, 2025 July 31, 2024 Organic Acquisitions Currency Total SALES BY SEGMENT Industrial Precision Solutions $ 970,079 $ 1,031,717 (5.7 )% — % (0.3 )% (6.0 )% Medical and Fluid Solutions 615,883 495,229 (7.1 )% 31.5 % — % 24.4 % Advanced Technology Solutions 453,905 418,493 8.0 % — % 0.5 % 8.5 % Total sales $ 2,039,867 $ 1,945,439 (3.1 )% 8.1 % (0.1 )% 4.9 % SALES BY GEOGRAPHIC REGION Americas $ 874,868 $ 855,456 (10.0 )% 13.1 % (0.8 )% 2.3 % Europe 526,878 540,750 (8.7 )% 5.0 % 1.1 % (2.6 )% Asia Pacific 638,121 549,233 13.1 % 3.1 % — % 16.2 % Total sales $ 2,039,867 $ 1,945,439 (3.1 )% 8.1 % (0.1 )% 4.9 % NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited) (Dollars in thousands) Three Months Ended Nine Months Ended July 31, 2025 July 31, 2024 July 31, 2025 July 31, 2024 Net income $ 125,784 $ 117,327 $ 332,840 $ 345,116 Income taxes 33,340 32,107 81,909 92,293 Interest expense - net 25,698 17,776 77,335 56,729 Other (income) expense - net 2,945 (152 ) 5,380 971 Depreciation and amortization 37,847 33,382 112,454 99,646 Inventory step-up amortization (1) — — 3,135 2,944 Severance and other (1) 451 2,536 16,725 4,615 Acquisition-related costs (1) 235 5,160 1,778 5,757 Divestiture and related charges (2) 12,211 — 12,211 — EBITDA (non-GAAP) (3) $ 238,511 $ 208,136 $ 643,767 $ 608,071 (1) Represents cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions. (2) Represents asset impairment and other charges associated with the exit of the medical contract manufacturing business. (3) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as cost reduction actions, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization. NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited) (Dollars in thousands) Three Months Ended Nine Months Ended July 31, 2025 July 31, 2024 July 31, 2025 July 31, 2024 SALES BY SEGMENT Industrial Precision Solutions $ 350,784 $ 348,997 $ 970,079 $ 1,031,717 Medical and Fluid Solutions 219,465 166,737 615,883 495,229 Advanced Technology Solutions 171,260 145,870 453,905 418,493 Total sales $ 741,509 $ 661,604 $ 2,039,867 $ 1,945,439 OPERATING PROFIT Industrial Precision Solutions $ 116,720 $ 115,023 $ 308,153 $ 340,043 Medical and Fluid Solutions 52,500 48,374 150,241 143,467 Advanced Technology Solutions 36,877 26,032 86,558 65,029 Corporate (18,330 ) (22,371 ) (47,488 ) (53,430 ) Total operating profit $ 187,767 $ 167,058 $ 497,464 $ 495,109 OPERATING PROFIT ADJUSTMENTS (1) Industrial Precision Solutions $ — $ 2,536 $ 9,823 $ 6,077 Medical and Fluid Solutions 12,968 — 19,589 — Advanced Technology Solutions (71 ) — 3,217 2,078 Corporate — 5,160 1,220 5,161 Total adjustments $ 12,897 $ 7,696 $ 33,849 $ 13,316 DEPRECIATION & AMORTIZATION Industrial Precision Solutions $ 13,410 $ 13,047 $ 38,477 $ 38,404 Medical and Fluid Solutions 17,685 13,553 54,193 40,822 Advanced Technology Solutions 4,740 4,841 14,058 14,509 Corporate 2,012 1,941 5,726 5,911 Total depreciation & amortization $ 37,847 $ 33,382 $ 112,454 $ 99,646 EBITDA (NON-GAAP) (2) Industrial Precision Solutions $ 130,130 37 % $ 130,606 37 % $ 356,453 37 % $ 384,524 37 % Medical and Fluid Solutions 83,153 38 % 61,927 37 % 224,023 36 % 184,289 37 % Advanced Technology Solutions 41,546 24 % 30,873 21 % 103,833 23 % 81,616 20 % Corporate (16,318 ) (15,270 ) (40,542 ) (42,358 ) Total EBITDA $ 238,511 32 % $ 208,136 31 % $ 643,767 32 % $ 608,071 31 % (1) Represents cost reduction actions, fees and non-cash inventory charges associated with acquisitions, and asset impairment and other charges associated with the exit of the medical contract manufacturing business. (2) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as cost reduction actions, fees and non-cash inventory charges associated with acquisitions and business exit costs, plus depreciation and amortization. NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited) (Dollars in thousands) Three Months Ended Nine Months Ended July 31, 2025 July 31, 2024 July 31, 2025 July 31, 2024 GAAP AS REPORTED Operating profit $ 187,767 $ 167,058 $ 497,464 $ 495,109 Other / interest expense - net (28,643 ) (17,624 ) (82,715 ) (57,700 ) Net income 125,784 117,327 332,840 345,116 Diluted earnings per share $ 2.22 $ 2.04 $ 5.83 $ 5.99 Shares outstanding - diluted 56,728 57,624 57,084 57,620 OPERATING PROFIT ADJUSTMENTS Inventory step-up amortization $ — $ — $ 3,135 $ 2,944 Acquisition costs 235 5,160 1,778 5,757 Severance and other 451 2,536 16,725 4,615 Divestiture and related charges 12,211 — 12,211 — ACQUISITION AMORTIZATION OF INTANGIBLES $ 20,092 $ 19,202 59,099 57,412 NON-OPERATING EXPENSE ADJUSTMENTS Entity liquidation $ — $ — $ 988 $ — Total adjustments $ 32,989 $ 26,898 $ 93,936 $ 70,728 Adjustments net of tax $ 29,084 $ 21,134 $ 78,451 $ 55,804 EPS effect of adjustments $ 0.51 $ 0.37 $ 1.37 $ 0.97 NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE Net income (1) $ 154,868 $ 138,461 $ 411,291 $ 400,920 Diluted earnings per share (2) $ 2.73 $ 2.41 $ 7.20 $ 6.96 (1) Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items. Refer to the "Reconciliation of Non-GAAP measures - EBITDA" table for definition of adjustments to operating income. (2) Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items. NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - OPERATING CASH FLOW TO FREE CASH FLOW (Unaudited) (Dollars in thousands) Year to Date July 31, 2025 April 30, 2025 Net cash provided by operating activities $ 516,264 $ 278,292 Additions to property, plant and equipment (49,002 ) (37,439 ) Free Cash Flow - Year to Date (1) $ 467,262 $ 240,853 Free Cash Flow - Quarter to Date (1) $ 226,409 Net Income - Year to Date $ 332,840 $ 345,116 Free Cash Flow Conversion - Year to Date (2) 140 % 70 % Net Income - Quarter to Date $ 125,784 Free Cash Flow Conversion - Quarter to Date (2) 180 % Year to Date July 31, 2024 April 30, 2024 Net cash provided by operating activities $ 459,812 $ 294,964 Additions to property, plant and equipment (43,786 ) (21,907 ) Free Cash Flow - Year to Date (1) $ 416,026 $ 273,057 Free Cash Flow - Quarter to Date (2) $ 142,969 (1) Free Cash Flow is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Net cash provided by operating activities minus Additions to property, plant and equipment. (2) Free Cash Flow Conversion is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Free Cash Flow divided by Net Income. Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding. View source version on Contacts Lara MahoneyVice President, Investor Relations & Corporate Sign in to access your portfolio
